Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatitis | 2 | 2021 | 139 | 0.290 |
Why?
|
| Purpura, Thrombocytopenic, Idiopathic | 1 | 2025 | 66 | 0.210 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2025 | 148 | 0.210 |
Why?
|
| Respite Care | 1 | 2024 | 1 | 0.210 |
Why?
|
| Resilience, Psychological | 1 | 2024 | 84 | 0.180 |
Why?
|
| Stroke | 2 | 2020 | 1061 | 0.180 |
Why?
|
| Exercise | 2 | 2025 | 892 | 0.180 |
Why?
|
| Health Promotion | 1 | 2025 | 422 | 0.170 |
Why?
|
| Multiple Sclerosis | 1 | 2025 | 395 | 0.170 |
Why?
|
| Social Support | 1 | 2024 | 370 | 0.170 |
Why?
|
| Spinal Cord Injuries | 1 | 2024 | 273 | 0.160 |
Why?
|
| Psychometrics | 1 | 2024 | 678 | 0.150 |
Why?
|
| Multiple Organ Failure | 1 | 2021 | 145 | 0.150 |
Why?
|
| Cardiolipins | 1 | 2019 | 20 | 0.150 |
Why?
|
| Mitochondria, Heart | 1 | 2019 | 58 | 0.140 |
Why?
|
| Insulin Resistance | 1 | 2023 | 690 | 0.130 |
Why?
|
| Problem Solving | 1 | 2018 | 61 | 0.130 |
Why?
|
| Caregivers | 1 | 2024 | 598 | 0.130 |
Why?
|
| Neuraminic Acids | 1 | 2017 | 2 | 0.130 |
Why?
|
| Low Back Pain | 1 | 2018 | 42 | 0.130 |
Why?
|
| Antibodies | 1 | 2017 | 322 | 0.120 |
Why?
|
| Antidepressive Agents | 1 | 2018 | 321 | 0.110 |
Why?
|
| Psychotherapy | 1 | 2018 | 250 | 0.110 |
Why?
|
| Cardiomyopathies | 1 | 2019 | 514 | 0.100 |
Why?
|
| Brain Injuries | 1 | 2019 | 710 | 0.100 |
Why?
|
| Tissue Donors | 1 | 2016 | 506 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1168 | 0.080 |
Why?
|
| Middle Aged | 8 | 2025 | 28601 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 558 | 0.080 |
Why?
|
| Kidney | 1 | 2016 | 1282 | 0.080 |
Why?
|
| Depression | 1 | 2018 | 1320 | 0.070 |
Why?
|
| Male | 10 | 2025 | 64957 | 0.070 |
Why?
|
| Female | 10 | 2025 | 70963 | 0.070 |
Why?
|
| Adult | 6 | 2025 | 31282 | 0.060 |
Why?
|
| Humans | 13 | 2025 | 131163 | 0.060 |
Why?
|
| Rho(D) Immune Globulin | 1 | 2025 | 14 | 0.060 |
Why?
|
| Aged | 5 | 2024 | 21025 | 0.060 |
Why?
|
| Hospital Mortality | 2 | 2020 | 1064 | 0.050 |
Why?
|
| Community-Based Participatory Research | 1 | 2025 | 65 | 0.050 |
Why?
|
| Comorbidity | 2 | 2020 | 1595 | 0.050 |
Why?
|
| Self-Management | 1 | 2025 | 120 | 0.050 |
Why?
|
| Factor Analysis, Statistical | 1 | 2024 | 237 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2025 | 333 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 6797 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2020 | 3359 | 0.050 |
Why?
|
| Chromatography, Liquid | 1 | 2023 | 235 | 0.040 |
Why?
|
| Risk Factors | 3 | 2021 | 11074 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2025 | 12936 | 0.040 |
Why?
|
| Self Report | 1 | 2024 | 554 | 0.040 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2023 | 289 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 1267 | 0.040 |
Why?
|
| Pennsylvania | 1 | 2020 | 60 | 0.040 |
Why?
|
| Retrospective Studies | 3 | 2025 | 17753 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 208 | 0.040 |
Why?
|
| Inpatients | 1 | 2024 | 562 | 0.040 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2019 | 64 | 0.040 |
Why?
|
| Carotid Stenosis | 1 | 2020 | 106 | 0.040 |
Why?
|
| Demography | 1 | 2019 | 237 | 0.040 |
Why?
|
| Venlafaxine Hydrochloride | 1 | 2018 | 20 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2019 | 436 | 0.030 |
Why?
|
| Galactosyltransferases | 1 | 2017 | 8 | 0.030 |
Why?
|
| Membrane Cofactor Protein | 1 | 2017 | 10 | 0.030 |
Why?
|
| Mixed Function Oxygenases | 1 | 2017 | 36 | 0.030 |
Why?
|
| Galactose | 1 | 2017 | 53 | 0.030 |
Why?
|
| ABO Blood-Group System | 1 | 2017 | 61 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 2904 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2017 | 186 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2017 | 210 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 1153 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2019 | 1105 | 0.030 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2019 | 229 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 204 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2020 | 1240 | 0.030 |
Why?
|
| Heart Arrest | 1 | 2019 | 356 | 0.030 |
Why?
|
| Disease Progression | 1 | 2021 | 2200 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1216 | 0.030 |
Why?
|
| Adolescent | 2 | 2025 | 20987 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 10103 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2017 | 786 | 0.030 |
Why?
|
| Swine | 1 | 2017 | 1186 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2017 | 523 | 0.030 |
Why?
|
| Length of Stay | 1 | 2019 | 1421 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 4066 | 0.020 |
Why?
|
| Age Factors | 1 | 2020 | 2825 | 0.020 |
Why?
|
| Rats | 1 | 2019 | 3370 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2021 | 3061 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2017 | 2885 | 0.020 |
Why?
|
| Vaccination | 1 | 2017 | 1060 | 0.020 |
Why?
|
| Obesity | 1 | 2023 | 2426 | 0.020 |
Why?
|
| Hospitalization | 1 | 2019 | 1950 | 0.020 |
Why?
|
| Diet | 1 | 2017 | 1121 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2020 | 3711 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6459 | 0.020 |
Why?
|
| Time Factors | 1 | 2020 | 6196 | 0.020 |
Why?
|
| Infant | 1 | 2025 | 13352 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2025 | 15110 | 0.020 |
Why?
|
| United States | 1 | 2024 | 12072 | 0.020 |
Why?
|
| Animals | 2 | 2019 | 33912 | 0.020 |
Why?
|
| Child | 1 | 2025 | 26341 | 0.010 |
Why?
|